After the genomics gold rush comes pretomics

Article Abstract:

Proteomics is defined as being the characterization of relative abundance, all structures and functions, and the interactions of the complement of proteins in a given entity. By contrast, genomics is defined as obtaining and understanding the complement of genetic information available to a given organism. As such, proteomics is a subset of genomics. This article discusses changes brought about by recent research in both fields upon the other fields.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug target pharmacogenomics

Article Abstract:

The field of pharmacogenomics has as its goal to better understand the genetic contribution to that interpatient variability in drug response. This article provides an overview of this field, including current research limitations.

Genetic aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Harnessing the power of genomics and proteomics. Part 1: Getting to grips with genomics

Article Abstract:

Technological advancement in genomics and proteomics discovery will mean big business for the diagnostic and pharmaceutical industry. Experts are expecting the molecular diagnostic market to grow in double-digit by 2007.

United States, Pharmaceutical preparations, Pharmaceutical research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Forecasts and trends, Market trend/market analysis, Proteomics, Genomics, Pharmaceutical industry
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.